Browse

Want to chat?

Call us toll free +1 (267) 388-9828

Social

Cart

Remove item Thumbnail image Product Price Quantity Subtotal
× Get the AML ETO t(8;21) Gene Rearrangement Quantitative MRD Monitor Test for only $188 in USA. Advanced Real-Time PCR technology detects minimal residual disease in acute myeloid leukemia patients. Available in New York AML ETO t(8;21) Gene Rearrangement Quantitative MRD Monitor Test $188
$188

Cart totals

Subtotal $188
Total $188
Proceed to checkout

Certified & Accredited

Our laboratory meets international standards—ISO certified—ensuring hospitals receive trusted, high-quality genetic results.

Clinical Precision

We use advanced sequencing technology for accurate DNA and genetic testing, supporting doctors in delivering reliable diagnoses and personalized patient care.

Rapid Turnaround

Get test results in as little as short time as possible, helping hospitals make fast, informed treatment decisions.

Expert Support

Hospital teams get direct access to our certified genetic counselors and technical experts for seamless, professional collaboration and guidance.